Deo Y - Search Results

1

G-CSF-stimulated PMN in immunotherapy of breast cancer with a bispecific antibody to Fc gamma RI and to HER-2/neu (MDX-210).

Repp R, Valerius T, Wieland G, Becker W, Steininger H, Deo Y, Helm G, Gramatzki M, Van de Winkel JG, Lang N, et al. Repp R, et al. Among authors: deo y. J Hematother. 1995 Oct;4(5):415-21. doi: 10.1089/scd.1.1995.4.415. J Hematother. 1995. PMID: 8581378 Review.

2

HLA class II as potential target antigen on malignant B cells for therapy with bispecific antibodies in combination with granulocyte colony-stimulating factor.

Elsässer D, Valerius T, Repp R, Weiner GJ, Deo Y, Kalden JR, van de Winkel JG, Stevenson GT, Glennie MJ, Gramatzki M. Elsässer D, et al. Among authors: deo y. Blood. 1996 May 1;87(9):3803-12. Blood. 1996. PMID: 8611706 Free article.

3

FcalphaRI (CD89) as a novel trigger molecule for bispecific antibody therapy.

Valerius T, Stockmeyer B, van Spriel AB, Graziano RF, van den Herik-Oudijk IE, Repp R, Deo YM, Lund J, Kalden JR, Gramatzki M, van de Winkel JG. Valerius T, et al. Among authors: deo ym. Blood. 1997 Dec 1;90(11):4485-92. Blood. 1997. PMID: 9373259 Free article.

4

Phase I clinical trial of the bispecific antibody MDX-H210 (anti-FcgammaRI x anti-HER-2/neu) in combination with Filgrastim (G-CSF) for treatment of advanced breast cancer.

Repp R, van Ojik HH, Valerius T, Groenewegen G, Wieland G, Oetzel C, Stockmeyer B, Becker W, Eisenhut M, Steininger H, Deo YM, Blijham GH, Kalden JR, van de Winkel JG, Gramatzki M. Repp R, et al. Among authors: deo ym. Br J Cancer. 2003 Dec 15;89(12):2234-43. doi: 10.1038/sj.bjc.6601367. Br J Cancer. 2003. PMID: 14676800 Free PMC article. Clinical Trial.

5

Preclinical studies with Fc(gamma)R bispecific antibodies and granulocyte colony-stimulating factor-primed neutrophils as effector cells against HER-2/neu overexpressing breast cancer.

Stockmeyer B, Valerius T, Repp R, Heijnen IA, Bühring HJ, Deo YM, Kalden JR, Gramatzki M, van de Winkel JG. Stockmeyer B, et al. Among authors: deo ym. Cancer Res. 1997 Feb 15;57(4):696-701. Cancer Res. 1997. PMID: 9044847

6

Clinical significance of IgG Fc receptors and Fc gamma R-directed immunotherapies.

Deo YM, Graziano RF, Repp R, van de Winkel JG. Deo YM, et al. Immunol Today. 1997 Mar;18(3):127-35. doi: 10.1016/s0167-5699(97)01007-4. Immunol Today. 1997. PMID: 9078685 Review.

7

Clinical trials of bispecific antibody MDX-210 in women with advanced breast or ovarian cancer that overexpresses HER-2/neu.

Valone FH, Kaufman PA, Guyre PM, Lewis LD, Memoli V, Ernstoff MS, Wells W, Barth R, Deo Y, Fisher J, et al. Valone FH, et al. Among authors: deo y. J Hematother. 1995 Oct;4(5):471-5. doi: 10.1089/scd.1.1995.4.471. J Hematother. 1995. PMID: 8581387 Clinical Trial.

8

Bifunctional NHS-BAT ester for antibody conjugation and stable technetium-99m labeling: conjugation chemistry, immunoreactivity and kit formulation.

Eisenhut M, Lehmann WD, Becker W, Behr T, Elser H, Strittmatter W, Steinsträsser A, Baum RP, Valerius T, Repp R, Deo Y. Eisenhut M, et al. Among authors: deo y. J Nucl Med. 1996 Feb;37(2):362-70. J Nucl Med. 1996. PMID: 8667077 Free article.

9

Targeting weak antigens to CD64 elicits potent humoral responses in human CD64 transgenic mice.

Keler T, Guyre PM, Vitale LA, Sundarapandiyan K, van De Winkel JG, Deo YM, Graziano RF. Keler T, et al. Among authors: deo ym. J Immunol. 2000 Dec 15;165(12):6738-42. doi: 10.4049/jimmunol.165.12.6738. J Immunol. 2000. PMID: 11120792

10

Bispecific antibody-dependent cellular cytotoxicity of HER2/neu-overexpressing tumor cells by Fc gamma receptor type I-expressing effector cells.

Keler T, Graziano RF, Mandal A, Wallace PK, Fisher J, Guyre PM, Fanger MW, Deo YM. Keler T, et al. Among authors: deo ym. Cancer Res. 1997 Sep 15;57(18):4008-14. Cancer Res. 1997. PMID: 9307286

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters